baber/WOPTO huggingface dataset:
Patent BR-112019012171-B1 (BR)
Title: novas formas de dosagem oral de liberação modificada e imediata de tebipenem pivoxil
Inventor: FRACZKIEWICZ GRAZYNA
IPC: A61K9/28
Filed: 2017-12-15
Abstract: Formas de dosagem oral de liberação imediata e modificada de tebipenem pivoxil incluindo núcleos de forma de dosagem são fornecidas. O núcleo da forma de dosagem inclui tebipenem pivoxil na forma de base ou sal livre, e excipientes incluindo um ligante, um lubrificante, opcionalmente um diluente, e excipientes adicionais opcionais. A razão de peso para peso de tebipenem pivoxil para os excipientes no núcleo da forma de dosagem é de 30:60 a 60:30. A divulgação inclui métodos de tratamento de infecções bacterianas, incluindo infecções complicadas do trato urinário.
Patent BR-112019026618-B1 (BR)
Title: Método de comunicação de sinal de referência, dispositivo de rede e dispositivo terminal e meio de armazenamento de computador
Inventor: XU MINGHUI
IPC: H04L25/03
Filed: 2018-06-14
Abstract: MÉTODO DE TRANSMISSÃO DE SINAL DE REFERÊNCIA E APARELHO DE TRANSMISSÃO Este pedido fornece um método de transmissão de sinal de referência e um aparelho de transmissão. O método de transmissão inclui: a obtenção, por um dispositivo de rede, de informações de referência de um dispositivo terminal, onde as informações de referência incluem pelo menos um de um identificador do dispositivo terminal e informações de programação do dispositivo terminal; determinar, pelo dispositivo de rede, um parâmetro de transmissão de um sinal de referência de rastreamento de fase (PTRS) do dispositivo terminal com base na informação de referência, em que o parâmetro de transmissão inclui pelo menos uma de uma sequência do PTRS e uma posição de domínio de frequência do PTRS; e transmitir, pelo dispositivo de rede, o PTRS com o dispositivo terminal com base no parâmetro de transmissão. De acordo com o método de transmissão de sinal de referência e aparelho de transmissão fornecidos em modalidades deste pedido, a interferência com o PTRS pode ser randomizada.
Patent BR-122019006884-B1 (BR)
Title: Formulações de longa ação de insulinas e seus usos
Inventor: REINHARD BECKER
IPC: A61K31/00
Filed: 2011-05-18
Abstract: O pedido refere-se a uma formulação farmacêutica aquosa compreendendo 200 a 1000 U/mL [equimolar a 200 a 1000 IU de insulina huma-na] de insulina glargina, com a condição de que a concentração da referida formulação não seja 684 U/mL de insulina glargina, e seu uso.
Patent BR-122021008351-B1 (BR)
Title: Tinta de impressão ou composição de revestimento, processo para preparar um substrato revestido com uma tinta ou uma composição impressa no mesmo, substrato revestido, e, artigo
Inventor: BUTLER GARY
IPC: C08F220/06
Filed: 2015-08-19
Abstract: A presente invenção fornece uma composição de tinta de impressão ou de revestimento que compreende um polímero acrílico de autorreticulação, um coalescente e uma emulsão de silicone, em que o polímero acrílico de autorreticulação tem uma temperatura de transição vítrea superior a 25°C. Além disso, a presente invenção também fornece um processo para preparar um substrato revestido, em particular um substrato de polyboard e um artigo feito a partir do substrato revestido, tal como embalagem de leite ou de suco.
Patent CS-201010-B2 (CS)
Title: Process for preparing derivatives of bis/nitrosoureido/-polyoles
Inventor: HORVATH TIBOR
IPC: C07C239/00
Filed: 1978-07-13
Abstract: The invention relates to bis(nitrosoureido)-polyol derivatives of general formula I B1-A-B2 (I)  wherein A stands for an open chain polyol comprising 4 to 6 carbon atoms or a six-membered cyclic polyol, and B1 and B2 being attached to two different carbon atoms of the chain A, are identical or different, and stand for a group of general formula II    <IMAGE>  (II)  wherein X stands for a halogen atom and Y and Z stand for a hydrogen atom or a nitroso group, with the restriction, that in B1 and B2 Y and Z must be different. The above compounds possess valuable cytostatic activity.
Patent CS-244907-B2 (CS)
Title: Preparation method of 2,4-diamino-5-/3,4,5-trimethoxybenzyl/-pyriminine
Inventor: BECK IVAN
IPC: C07D239/48
Filed: 1982-06-24
Abstract: 2,4-Diamino-5-/3',4',5'-trimethoxybenzyl/pyrimidine is prepared by reacting alpha-/3,4,5-trimethoxy-benzal/-beta-methoxypropionitrile with a diethylene glycol monalkyl ether of the formula HO-CH2-CH2-O-CH2-CH2-OR (wherein R is an alkyl group having 1 to 4 carbon atoms) at 60 to 90 DEG C in the presence of an alkali metal alkoxide, and reacting the obtained benzyl isomer of the formula   <IMAGE> (optionally without separation) with guanidine in the presence of an alkanol having 4 to 8 carbon atoms.
Patent CS-208668-B2 (CS)
Title: Method of making the derivatives of the 20-methyl-13,14-didehydro-pgi2
Inventor: GANDOLFI CARMELO
IPC: C07C405/00
Filed: 1979-07-20
Abstract: 20-Methyl-13, 14-didehydro- PGl2 derivatives of formula:   <IMAGE> where R is hydrogen or methyl and M is hydrogen or a pharmaceutically acceptable cation have a greater effect than PGl2 or 20-methyl-PGl2 in disaggregating platelets in the bloodstream and in vasodilating action. They can be prepared by dehydrohalogenation of dihalo compounds of formula (II> <IMAGE> where R and M have the meanings given above and X1 and X2 are independently bromine, chlorine or iodine. A sodium or potassium alkoxide is the preferred dehydrohalogenating agent.
Patent CS-272776-B2 (CS)
Title: Method of paraffine extraction
Inventor: FAGGIAN LUCIO
IPC: C07C9/22
Filed: 1987-07-23
Abstract: Mixtures of C12-C18 n-paraffins with paraffinsulphonic acids having the same number of carbon atoms, water and sulphuric acid, and obtained by sulphoxidation of said paraffins with SO2 and O2 in the presence of water and UV radiation are stripped of their excess SO2 and decanted to separate most of the paraffins. and obtain a residual mixture. The residual mixture is fed with sulphuric acid until a two-phase system forms or at least until the mixture becomes turbid, and the turbid mixture or that floating on the heavy water-sulphuric acid phase is extraced with supercritical CO2, which removes with it the paraffins, which can be reused in the sulphoxidation process.
Patent AU-712370-B2 (AU)
Title: Quinazoline derivatives
Inventor: LOHMANN JEAN-JACQUES MARCEL
IPC: C07D239/86
Filed: 1996-12-13
Granted: 1999-11-04
Abstract: The invention relates to quinazoline derivatives of the formula: [wherein: Y1 represents -O-, -S-, -CH2-, -SO-, -SO2-, -NR5CO-, -CONR6-, -SO2NR7-, -NR8SO2- or -NR9- (wherein R5, R6, R7, R8 and R9 each independently represents hydrogen, alkyl or alkoxyalkyl); R1 represents hydrogen, hydroxy, halogeno, nitro, trifluoromethyl, cyano, alkyl, alkoxy, alkylthio, amino or alkylamino. R2 represents hydrogen, hydroxy, halogeno, alkyl, alkoxy, trifluoromethyl, cyano, amino or nitro; m is an integer from 1 to 5; R3 represents hydroxy, halogeno, alky, alkoxy, alkanoyloxy, trifluoromethyl, cyano, amino or nitro; R4 represents a group which is or which contains an optionally substituted pyridone, phenyl or aromatic heterocyclic group] and salts thereof; processes for their preparation and pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent AU-714465-B2 (AU)
Title: Bioartificial devices and cellular matrices therefor
Inventor: USALA ANTON-LEWIS
IPC: A61L27/22
Filed: 1996-11-14
Granted: 2000-01-06
Abstract: A hydrogel matrix for the storage, manufacture, functional testing, and viral infection testing of cellular moieties comprises 0.001 to 100m M gelatin, such as denatured collagen, and 0.01 to 1000  mu M of a cryoprolector, for example dextran. The matrix may further comprise 0.01 to 30 mM of a nitric oxide inhibitor such as an L-arginine analog. The hydrogel matrix may for example be used in treatments to increase vascularization.
Patent AU-602388-B2 (AU)
Title: A data processing system having features for automatic configuration of device cards
Inventor: HEATH CHESTER ASBURY
IPC: G06F12/06
Filed: 1988-03-07
Granted: 1990-10-11
Abstract: A data processing system includes a central processing unit (CPU), a main memory unit, and input/output (I/O) sockets, each adapted to receive a selected one of a plurality of different and/or similar option cards. Each card contains (or is connected to) and controls a respective peripheral device, and each card is pre-wired with an ID value corresponding to its card type. Programmable option registers on each card store parameters such as address information, priority levels, and other system resource parameters. A setup routine, during initial power-on, retrieves and stores the appropriate parameters in the I/O cards and also in socket locations in main memory, one location being assigned to each input/output socket. Each socket location is adapted to hold the parameters associated with the card inserted in its respective socket and the card ID value. That portion of main memory containing the socket locations is adapted to maintain the parameter and ID information by means of battery power when system power fails or is disconnected, i.e., a non-volatile memory portion. Subsequent power-on routines are simplified by merely transferring parameters from the memory to the card registers if the status of all the sockets has not changed since the last power-down.
Patent AU-695737-B2 (AU)
Title: Dispersion tolerant optical transmission
Inventor: PRICE ALISTAIR
IPC: H04L25/34
Filed: 1995-04-05
Granted: 1998-08-20
Abstract: PCT No. PCT/FR95/00510 Sec. 371 Date Dec. 13, 1995 Sec. 102(e) Date Dec. 13, 1995 PCT Filed Apr. 20, 1995 PCT Pub. No. WO95/29539 PCT Pub. Date Nov. 2, 1995An optical transmission method and device consisting of coding a binary data pattern (SI) to be transmitted in the form of a second binary signal (SM), by differential coding; filtering the second binary signal (SM) to obtain a duobinary signal (SMF having three meaningful values (-1, 0+/- epsilon , +a) and a narrower bandwidth; and modulating an optical carrier according to the values assumed by the filtered signal (SMF), the modulated carrier having a maximal amplitude to represent the maximal value (+a) and the minimal value (+a) of the duobinary signal (SMF), the phase of the modulated carrier being shifted by  theta 1 and  theta 2= theta 1+180 DEG , respectively, and a minimal amplitude to represent values (0+/- epsilon ) near 0 if the duobinary signal. The method of this invention is suitable for long distance fiber-optic transmissions.
Patent AU-647941-B2 (AU)
Title: Diamond synthesis
Inventor: BURNS ROBERT CHARLES
IPC: B01J3/06
Filed: 1992-07-09
Granted: 1994-03-31
Abstract: A reaction vessel for use in producing large diamond crystals of good quality and yield includes a reaction volume and a reaction mass located in the volume. The reaction mass comprises a plurality of seed particles (24) located in or on a surface (26) in the reaction volume and a carbon source (22) separated from the seed particles (24) by a mass of metallic catalyst/solvent (20) for diamond synthesis. The mass (20) comprises alternating layers (30, 32) of carbon-rich and carbon-lean metallic catalyst/solvent which lie parallel or substantially parallel to the surface (26). There is also provided a mass (18) of alternating layers (30, 32) of carbon-rich and carbon-lean metallic catalyst/solvent. <IMAGE>
Patent AU-688880-B2 (AU)
Title: Recombinant humanized anti-FB5 antibodies
Inventor: WALLACE THOMAS P
IPC: C07K16/30
Filed: 1995-03-08
Granted: 1998-03-19
Abstract: The invention provides for the production of several humanized murine antibodies specific for the antigen FB5, which is recognized by the murine antibody FB5. The FB5 antigen is expressed on the luminal surface of vascular endothelial cells of a wide range of malignant tumours. The invention also provides for numerous polynucleotide encoding humanized FB5 specific antibodies, expression vectors for producing humanized FB5 specific antibodies, and host cells for the recombinant production of the humanized antibodies. The invention also provides methods for detecting cancerous cells (in vitro and in vivo) using humanized FB5 specific antibodies. Additionally, the invention provides methods of treating cancer using FB5 specific antibodies.
Patent AU-707149-B2 (AU)
Title: Spraying devices
Inventor: NOAKES TIMOTHY JAMES
IPC: B05B5/057
Filed: 1995-04-24
Granted: 1999-07-01
Abstract: An electrostatic spraying device for use in spraying inter alia personal care and personal hygiene products comprises an outlet (94) from which the product issues in the form of an electrostatically charged spray and a control member (60, 60a) for attenuating the potential gradient in the vicinity of the outlet (94) to such an extent that spraying is suppressed until the device is brought to within a predetermined distance from a site to be spayed.
Patent AU-686796-B2 (AU)
Title: Separating and concentrating certain ions using ion-binding ligands bonded to membranes
Inventor: TARBET BRYON J
IPC: B01J45/00
Filed: 1995-04-25
Granted: 1998-02-12
Abstract: A method for removing, separating, and concentrating certain selected ions from a source solution that may contain larger concentrations of other ions comprises bringing the source solution in contact with a composition comprising an ion-binding ligand covalently bonded to a membrane having hydrophilic surface properties. The ligand portion of the composition has affinity for and forms a complex with the selected ions, thereby removing them from the source solution. The selected ions are then removed from the composition through contact with a much smaller volume of a receiving solution in which the selected ions are either soluble or which has greater affinity for the selected ions than does the ligand portion of the composition, thereby quantitatively stripping the complexed ions from the ligand and recovering them in concentrated form in the receiving solution. The concentrated ions thus removed may be further separated and recovered by known methods. The process is useful in the removal of selected ions, including noble metals and other transition metals from a variety of source solutions such as are encountered in semiconductor, nuclear waste cleanup, metals refining, environmental cleanup, providing ultra high purity fluids, electric power, and other industrial enterprises. The invention is also drawn to the ligand-membrane compositions.
Patent AU-768987-B2 (AU)
Title: A digital hearing aid with a voltage converter
Inventor: ANDERSEN HENNING HAUGARD
IPC: H04R25/00
Filed: 2001-01-05
Granted: 2004-01-15
Abstract: A digital hearing aid comprises a microphone (2), an output transducer (3), a digital signal processor (5) interconnected between the microphone and the output transducer, and a power source (7) including a standard hearing aid battery for the supply of operation voltage for the digital signal processor. At least one of the integrated circuit signal processing parts is designed to operate at a reduced unstabilized operation voltage substantially below a nominal voltage of the battery. A switched step-down voltage converter is connected between the power source and such signal processing parts for lowering the battery voltage to provide the reduced operation voltage.
Patent AU-605399-B2 (AU)
Title: Integrated unit for extracorporeal blood circuits
Inventor: PANZANI IVO
IPC: A61M1/36
Filed: 1989-01-10
Granted: 1991-01-10
Abstract: An integrated unit in extracorporeal blood circuit includes a tank (1) internally provided with a wall in defoaming material (2) having at least one filter (11), adapted to delimit at least laterally a portion of space inside which blood coming from the patient and from the operating field inflows, and thus such as to act simultaneously as venous tank and as cardiotome, said tank (1) being connected monolithically to a heat exchanger (15) and to an oxygenator (14) adapted to be traversed by the outflowing blood from said tank (1).
Patent AU-568879-B2 (AU)
Title: Surgical stapler
Inventor: GREEN DAVID THOMAS
IPC: A61B17/072
Filed: 1984-09-21
Granted: 1988-01-14
Abstract: In a surgical fastener applying instrument of the type in which the tissue is first clamped by operation of a lever mechanism, a releasable latch is included in the lever mechanism for releasably holding the tissue clamping elements at an intermediate latching position. In this position, the tissue to be fastened is enclosed but not fully clamped by the instrument so that the position of the instrument relative to the tissue can be adjusted without reopening the instrument.
Patent AU-618596-B2 (AU)
Title: Expression of hepatisis b s and pres2proteins in methylotrophic yeasts
Inventor: THILL GREGORY PATRICK
IPC: C12R1/865
Filed: 1989-05-12
Granted: 1992-01-02
Abstract: A process for the enhanced production of antigenic particles consisting essentially of hepatitis B S protein and preS2 protein. Also disclosed are novel DNA molecules and hosts transformed with these molecules.
Patent AU-689325-B2 (AU)
Title: Probe for diagnosing infectious diseases
Inventor: KESHI HIROYUKI
IPC: C12Q1/68
Filed: 1995-10-02
Granted: 1998-03-26
Abstract: A probe derived from phlogogenic bacteria of pneumonia, containing fragments of DNA which streptococcus pneumoniae essentially possesses, and useful for detecting and identifying causative bacteria of pneumonia is obtained by completely digesting the DNA with a restriction endonuclease PstI, followed by cloning into a suitable vector. <IMAGE>
Patent AU-622680-B2 (AU)
Title: Process and device for spectroscopic quantitative determination of gases in gas mixtures
Inventor: SZEPAN REINER
IPC: G01N21/31
Filed: 1989-05-31
Granted: 1992-04-16
Abstract: The invention relates to a device for spectroscopically determining concentrations of gases (4) in gaseous mixtures. In the method, periodically alternating monochromatic light (1) of at least two wavelengths is used, and the light (1) of at least one wavelength is characteristic, and the light (1) of at least one other wavelength is uncharacteristic of the transmission of the gas to be determined. This transmission generates electric signals which contain harmonic components of at least one odd Fourier frequence of an emission period of which the amplitude is proportional to the concentration of the gas (4) to be determined in the gaseous mixture and vanishes with the concentration. <IMAGE>
Patent AU-734452-B2 (AU)
Title: A method of forming a monolayer of particles, and products formed thereby
Inventor: MCARDLE CIARAN B
IPC: C09J11/04
Filed: 1997-08-01
Granted: 2001-06-14
Abstract: The present invention provides a number of interrelated methods for the production of random and ordered arrays of particles and recesses as well as films containing such arrays and recesses. The present invention also relates to the random and ordered arrays of particles and films prepared therefrom. The ordered arrays are obtained by the use of ferrofluid compositions which may be curable, solidifiable on non-curing/non-solidifiable. The arrays and films may contain electrically-conductive particles useful in electronic applications for effecting contact between leads or pads.
Patent AU-680824-B2 (AU)
Title: Suppression of T-cell proliferation using peptide fragments of myelin basic protein
Inventor: WEINER HOWARD L
IPC: A61K38/095
Filed: 1993-04-09
Granted: 1997-08-14
Abstract: Peptides derived from fragment 84-102 of hMBP by deleting one to four N-terminal amino acids and/or one to eight C-terminal amino acids and containing an alanine residue at position 85,86,87,88,89,90,91,92,93,94,95,96,97,98, or 99.These peptides are useful to suppress autoimmune responses.
Patent AU-770029-B2 (AU)
Title: Processes for preparing pesticidal intermediates
Inventor: ANCEL JEAN-ERICK
IPC: C07B61/00
Filed: 2000-03-30
Granted: 2004-02-12
Abstract: Compounds of formula (I) are prepared by hydrogenolysis of a compound of formula (II):where R1 is haloalkyl, haloalkoxy or -SF5; W is N or CR3; and R2 and R3 are H or Cl. The compounds of formula (I) can be used as intermediates in the preparation of pesticidally active arylpyrazole compounds.
Patent AU-667384-B2 (AU)
Title: Gas lubricated barrier seal
Inventor: WASSER JAMES R
IPC: F16J15/34
Filed: 1993-08-05
Granted: 1996-03-21
Abstract: A double, back to back oriented mechanical end face seal (10) for use in sealing toxic or corrosive fluids having an intermediate buffer fluid chamber (26) into which a relatively inert gas, such as nitrogen, is provided for use as a buffer fluid. The nitrogen gas is maintained at a pressure which exceeds the process fluid pressure by at least 10 p.s.i. and, in a preferred embodiment, spiral pumping grooves (44,74) in the mating rings (40,60) of each of the seals (22,24) are shaped and dimensioned to pump the nitrogen buffer gas through the first seal (22) from the intermediate chamber (26) into the process fluid chamber (12) and through the second seal (24) from the intermediate chamber (26) into the environment external to the housing (12) and sealing area, thereby avoiding the escape of the process fluid into the intermediate buffer chamber (26) and to the atmosphere. Contamination of the process fluid by the buffer gas may be tolerated. The buffer gas may be any relatively inert gas, a gas which is non-hazardous to the environment and also is compatible with the process fluid used; appropriate examples are nitrogen, carbon dioxide, air or one of the noble gases. The seal (10) can be used to seal a process fluid which is either a liquid or a gas. <IMAGE>
Patent AU-625276-B2 (AU)
Title: Pharmaceutical compositions
Inventor: BACHYNSKY MARIA OKSANA
IPC: A61K47/10
Filed: 1989-11-21
Granted: 1992-07-09
Abstract: Pharmaceutical product containing  (a) a compound with antibacterial activity, and (b) an effective amount of an absorption-promoting 2-component system which contains as first component (b 1) an ether composed of a C6-C18-alcohol and polyoxyethylene glycol and as second component either (b 2-1) a polyoxyethylene glycol C6-C18-carboxylic acid glyceride ester, or (b 2-2) a C6-C18-carboxylic acid or a pharmaceutically utilisable salt thereof, or (b 2-3) an ester composed of two or more C6-C18-carboxylic acids, glycerol and a polyoxyethylene glycol.
Patent AU-697790-B2 (AU)
Title: Hydrocarbon treatment and catalyst therefor
Inventor: VERRELST WIM HERMAN
IPC: B01J29/04
Filed: 1996-01-29
Granted: 1998-10-15
Abstract: A molecular sieve comprising a core having deposited thereon a surface layer, wherein the core is a zeolite containing silicon and at least one element selected from gallium and iron and the surface layer has a higher Si:Al ratio than that of the silicon:selected element ratio of the core, provides for lower branching in olefin oligomerization products.
Patent AU-591072-B2 (AU)
Title: Screening test for reverse-transcriptase containing virus
Inventor: SETO BELINDA PIK-LAN
IPC: C12Q1/48
Filed: 1985-10-10
Granted: 1989-11-30
Abstract: A single step method of screening blood and other sources for the presence of a reverse-transcriptase-containing virus comprising assaying a sample suspected of containing such a virus for the presence of particle-associated reverse-transcriptase activity.
Patent AU-588260-B2 (AU)
Title: A security bag
Inventor: WENDON PETER JOHN
IPC: B65D33/34
Filed: 1985-11-22
Granted: 1989-09-14
Abstract: A security bag (10) comprises front and rear panels (12, 13) in which the front panel (12) is extended to provide a flap (27) adjacent an opening of the bag (10) and the rear panel (13) is provided with a lip (20) also adjacent the opening which unites with the rear panel (13) by means of adhesive (21). The flap (27) is provided with adhesive (22) and a line of weakening (17). When the flap (27) is folded onto the rear panel (13) and is united therewith by the adhesive (22), the flap (27) also unites with the lip (20) by means of the adhesive (22). Any attempt to open the bag (10) by lifting the flap (27) from the rear panel (13) results in severing of the material of the flap (27) along the line of weakening (17).